Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Senescent fibroblasts can help start tumors in normal skin cells.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Microneedle radiofrequency helps skin repair and rejuvenate by activating fibroblasts and remodeling the skin's structure.

5% topical minoxidil improves hair density and quality in monilethrix patients.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

BMI1 is essential for preventing hair greying and maintaining hair color.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Geranium sibiricum may help manage diabetic complications by inhibiting a key enzyme.

OBEME effectively enhances wound healing and could be a promising carrier for skin treatments.

The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.

MED1 affects skin wound healing differently in young and old mice.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

CG2001 is safe and well-tolerated for treating hair loss in men.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

The α-MSH-MC1R-cAMP pathway does not protect skin cells from UVA damage.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.